Adage Capital Partners
ALNA

Adage Capital Partners’s Allena Pharmaceuticals ALNA Stock Holding History

Adage Capital Partners’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-343,574
Closed -$1.35M – 778
2019
Q3 		$1.35M Hold
343,574
– – ﹤0.01% 675
2019
Q2 		$1.4M Hold
343,574
– – ﹤0.01% 676
2019
Q1 		$2.41M Hold
343,574
– – 0.01% 646
2018
Q4 		$1.87M Hold
343,574
– – 0.01% 663
2018
Q3 		$3.69M Hold
343,574
– – 0.01% 654
2018
Q2 		$4.48M Buy
343,574
+259,414
+308% +$3.74M 0.01% 657
2018
Q1 		$927K Buy
+84,160
New +$703K ﹤0.01% 689

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return

Adage Capital Partners's ALNA Position: Q4 2019 in Review

Adage Capital Partners sold out of Allena Pharmaceuticals (ALNA) in Q4 2019, closing a stake of 343,574 shares — an estimated $1.35M sold.

Adage Capital Partners first reported a position in ALNA in Q1 2018 and held it in 7 quarters. The position peaked at $4.48M in Q2 2018. 26 funds tracked by Wall St. Rank hold ALNA as of Q4 2019.

  • Adage Capital Partners reported no remaining Allena Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Adage Capital Partners sold 343,574 Allena Pharmaceuticals shares in Q4 2019, an estimated $1.35M.
  • Adage Capital Partners first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Adage Capital Partners's Allena Pharmaceuticals position peaked at $4.48M in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2019.

Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.